An immune regulatory CCT repeat containing oligodeoxynucleotide capable of causing hair loss in male mice

Human & Experimental Toxicology
Y XuYongli Yu

Abstract

An oligodeoxynucleotide with CCT repeats (CCT ODN) has been found in our previous study to selectively downregulate Toll-like receptor 7/9 (TLR7/9)-mediated immune responses both in vitro and in vivo. In this study, we unexpectedly found that CCT ODN induced severe patchy hair loss around the mouth in male F1 mice (female Balb/c × male C57BL/6) with lupus-like nephritis induced by injecting allogenic lymphocytes and also in male Balb/c mice, but not in female F1 mice and Balb/c mice and either gender of C57BL/6 mice. Increased infiltration of natural killer group 2, member D (NKG2D+) cells in hair loss skin and upregulated interferon-gamma (IFN-γ) messenger RNA expression in cultured splenocytes were observed in male Balb/c mice. The CCT ODN-conditioned supernatants of cultured mouse splenocytes caused catagen-like changes to hair follicles (HFs). We hypothesized that the CCT ODN could induce patchy hair loss in the male mice with certain genetic traits by mobilizing NKG2D+ cells to HFs and by inducing the production of IFN-γ from immune cells. Taken together these data indicated that a gender and genetic preference of immune-regulatory oligonucleotides is causing unexpected clinical situations such as hair loss.

References

Mar 1, 1989·The Journal of Investigative Dermatology·A E BuhlJ M Holland
Nov 6, 1998·The Journal of Investigative Dermatology·K J McElweeJ P Sundberg
Feb 16, 2000·The Journal of Investigative Dermatology. Symposium Proceedings·R Hoffmann
Oct 25, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ryuichiro HirotaRyotaro Yoshida
Jan 13, 2006·The Journal of Investigative Dermatology. Symposium Proceedings·S SkurkovichB Skurkovich
Apr 18, 2006·Seminars in Cutaneous Medicine and Surgery·Karoline Krause, Kerstin Foitzik
Aug 17, 2006·The British Journal of Dermatology·P Freyschmidt-PaulM Zöller
Sep 16, 2006·Immunological Reviews·Sharon M WahlNiki Moutsopoulos
Mar 8, 2007·Critical Reviews in Immunology·Angela TrieuKatryn J Stacey
Jul 7, 2007·Immunology·Anita R Mistry, Chris A O'Callaghan
Aug 3, 2007·The Journal of Clinical Investigation·Amos GilharRichard S Kalish
Dec 28, 2007·The Journal of Investigative Dermatology·Taisuke ItoRalf Paus
Feb 24, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Liang YangLiying Wang
Dec 26, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ran SunLiying Wang
Feb 2, 2010·Journal of the American Academy of Dermatology·Abdullah AlkhalifahJerry Shapiro
Jul 28, 2010·Journal of the American Academy of Dermatology·Silke RedlerMarkus M Nöthen
Dec 21, 2010·Journal of Dermatological Science·Shigeki Inui, Satoshi Itami
Jan 8, 2011·Science·Eric VivierSophie Ugolini
May 31, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Chunyan HeYongli Yu
Jun 6, 2012·International Immunopharmacology·Yong-Sheng ZhangLi-Ying Wang
Sep 29, 2012·Experimental Dermatology·Shigeki Inui, Satoshi Itami
Oct 24, 2013·Clinical & Developmental Immunology·Taisuke Ito
Dec 12, 2013·The Journal of Investigative Dermatology. Symposium Proceedings·Ralf Paus, Marta Bertolini
Dec 12, 2013·The Journal of Investigative Dermatology. Symposium Proceedings·Amos GilharRalf Paus

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
protein assay
electrophoresis
fluorescence-activated
flow cytometry
dissecting
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.